Literature DB >> 28865973

Recovery of Pulmonary Function after Allogeneic Hematopoietic Cell Transplantation in Children is Associated with Improved Survival.

Ashok Srinivasan1, Anusha Sunkara2, William Mitchell3, Sudeep Sunthankar4, Guolian Kang2, Dennis C Stokes5, Saumini Srinivasan5.   

Abstract

Abnormal pulmonary function is prevalent in survivors of allogeneic hematopoietic cell transplantation (HCT). Post-transplantation recovery of pulmonary function, and its effect on survival, in children are not known. This retrospective cohort study of 308 children followed for 10 years after HCT at a single institution included 2 groups of patients. Group 1 comprised 188 patients with 3 or more pulmonary function test (PFT) results, of which at least 1 was abnormal, and group 2 comprised 120 patients with 3 or more PFTs, all of which were normal. Pulmonary function normalized post-transplantation in 51 patients (27%) in group 1. Obstructive lung disease, restrictive lung disease, mixed lung disease, and normal pattern were seen in 43%, 25%, 5%, and 27% of patients, respectively, at a median of 5 years (range, 0.5 to 11.9 years) post-transplantation. Lung volumes recovered better than spirometric indices. Pulmonary complications were seen in 80 patients (43%) in group 1. Patients who recovered pulmonary function had better overall survival (P = .006), which did not differ significantly from that in patients in group 2 with normal lung function post-transplantation (P = .80). After adjusting for duration of follow-up, pulmonary complications (P = .01), and lower pretransplantation forced vital capacity z-scores (P = .01) were associated with poor recovery. T cell depletion (P < .001), lower pretransplantation forced expired volume in 1 second z-scores (P = .006), and chronic graft-versus-host disease (P < .001) increased the risk for pulmonary complications. Nonrecovery of lung function with pulmonary complications (P = .03), acute graft-versus-host disease (P = .004), and mechanical ventilation (P < .001) were risk factors for nonrelapse mortality. Normalization of pulmonary function is possible in long-term survivors of allogeneic HCT. Strategies to decrease the risk of pulmonary complications may improve outcomes.
Copyright © 2017 The American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Hematopoietic cell transplantation; Lung function; Pediatric; Recovery; Survival

Mesh:

Year:  2017        PMID: 28865973      PMCID: PMC5711551          DOI: 10.1016/j.bbmt.2017.08.025

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  32 in total

Review 1.  Pulmonary dysfunction in pediatric hematopoietic stem cell transplant patients: non-infectious and long-term complications.

Authors:  W Adam Gower; J Michael Collaco; Peter J Mogayzel
Journal:  Pediatr Blood Cancer       Date:  2007-09       Impact factor: 3.167

Review 2.  An official American Thoracic Society research statement: noninfectious lung injury after hematopoietic stem cell transplantation: idiopathic pneumonia syndrome.

Authors:  Angela Panoskaltsis-Mortari; Matthias Griese; David K Madtes; John A Belperio; Imad Y Haddad; Rodney J Folz; Kenneth R Cooke
Journal:  Am J Respir Crit Care Med       Date:  2011-05-01       Impact factor: 21.405

3.  Pulmonary diffusing capacity in healthy African-American and Caucasian children.

Authors:  Young-Jee Kim; Kathy Christoph; Zhangsheng Yu; Howard Eigen; Robert S Tepper
Journal:  Pediatr Pulmonol       Date:  2015-04-23

4.  The analysis of failure times in the presence of competing risks.

Authors:  R L Prentice; J D Kalbfleisch; A V Peterson; N Flournoy; V T Farewell; N E Breslow
Journal:  Biometrics       Date:  1978-12       Impact factor: 2.571

5.  Increased risk of chronic graft-versus-host disease, obstructive bronchiolitis, and alopecia with busulfan versus total body irradiation: long-term results of a randomized trial in allogeneic marrow recipients with leukemia. Nordic Bone Marrow Transplantation Group.

Authors:  O Ringdén; M Remberger; T Ruutu; J Nikoskelainen; L Volin; L Vindeløv; T Parkkali; S Lenhoff; B Sallerfors; L Mellander; P Ljungman; N Jacobsen
Journal:  Blood       Date:  1999-04-01       Impact factor: 22.113

6.  Pre-hematopoietic stem cell transplant lung function and pulmonary complications in children.

Authors:  Ashok Srinivasan; Saumini Srinivasan; Sudeep Sunthankar; Anusha Sunkara; Guolian Kang; Dennis C Stokes; Wing Leung
Journal:  Ann Am Thorac Soc       Date:  2014-12

7.  Pre-transplant lung function is predictive of survival following pediatric bone marrow transplantation.

Authors:  Jill P Ginsberg; Richard Aplenc; Joseph McDonough; James Bethel; John Doyle; Daniel J Weiner
Journal:  Pediatr Blood Cancer       Date:  2010-03       Impact factor: 3.167

8.  Lung volumes in healthy nonsmoking adults.

Authors:  R O Crapo; A H Morris; P D Clayton; C R Nixon
Journal:  Bull Eur Physiopathol Respir       Date:  1982 May-Jun

9.  Repair of impaired pulmonary function is possible in very-long-term allogeneic stem cell transplantation survivors.

Authors:  Natasha A Jain; Priyanka A Pophali; Jeffrey K Klotz; Sawa Ito; Eleftheria Koklanaris; Kamna Chawla; Christopher S Hourigan; Nicole Gormley; Bipin N Savani; Austin John Barrett; Minoo Battiwalla
Journal:  Biol Blood Marrow Transplant       Date:  2013-11-02       Impact factor: 5.742

Review 10.  A Critical Care and Transplantation-Based Approach to Acute Respiratory Failure after Hematopoietic Stem Cell Transplantation in Children.

Authors:  Lama Elbahlawan; Ashok Srinivasan; R Ray Morrison
Journal:  Biol Blood Marrow Transplant       Date:  2015-09-25       Impact factor: 5.742

View more
  3 in total

1.  Pulmonary Complications of Pediatric Hematopoietic Cell Transplantation. A National Institutes of Health Workshop Summary.

Authors:  Robert F Tamburro; Kenneth R Cooke; Stella M Davies; Samuel Goldfarb; James S Hagood; Ashok Srinivasan; Marie E Steiner; Dennis Stokes; Nancy DiFronzo; Nahed El-Kassar; Nonniekaye Shelburne; Aruna Natarajan
Journal:  Ann Am Thorac Soc       Date:  2021-03

2.  Pulmonary Manifestations of GATA2 Deficiency.

Authors:  Beatriz E Marciano; Kenneth N Olivier; Les R Folio; Christa S Zerbe; Amy P Hsu; Alexandra F Freeman; Armando C Filie; Michael A Spinner; Lauren A Sanchez; Jana P Lovell; Mark Parta; Jennifer M Cuellar-Rodriguez; Dennis D Hickstein; Steven M Holland
Journal:  Chest       Date:  2021-06-03       Impact factor: 10.262

3.  Pulmonary complications after hematopoietic stem cell transplantation in children: a functional and tomographic evaluation.

Authors:  Débora Carla Chong-Silva; Pollyana Moreira Schneider; Tyane de Almeida Pinto Jardim; Samantha Nichele; Gisele Loth; Carlos Antônio Riedi; Herberto José Chong Neto; Carmen Maria Sales Bonfim; Nelson Augusto Rosário Filho
Journal:  J Bras Pneumol       Date:  2022-09-26       Impact factor: 2.800

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.